Mithra Pharmaceuticals SA logo

Mithra Pharmaceuticals SA

FRA:1TM (Belgium)  
€ 0.23 (-10.85%) Mar 28
At Loss
Market Cap:
€ 18.67M ($ 20.14M)
Enterprise V:
€ 202.72M ($ 218.68M)
Volume:
-
Avg Vol (2M):
1.33K
Also Trade In:

Business Description

Description
Mithra Pharmaceuticals SA develops products for women's health with a particular focus on fertility, contraception, and menopause. It operates in three segments: Product Sales, Out-licensing, and Other. The company also develops and markets complex therapeutic solutions and offers partners a complete spectrum of research, development, and specialist manufacturing at its Mithra CDMO. Its geographical segments are Belgium, Europe and Outside Europe.
Name Current Vs Industry Vs History
Cash-To-Debt 0.11
Equity-to-Asset -0.02
Debt-to-Equity -23.8
Debt-to-EBITDA -157.4
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1
Distress
Grey
Safe
Beneish M-Score -0.95
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 51.74
9-Day RSI 41.62
14-Day RSI 35.06
6-1 Month Momentum % -69.95
12-1 Month Momentum % -82.2

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.04
Quick Ratio 0.49
Cash Ratio 0.27
Days Inventory 858.52
Days Sales Outstanding 65.7
Days Payable 603.42

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -12.9
Shareholder Yield % -8.42

Financials (Next Earnings Date:2024-09-26 Est.)

FRA:1TM's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Mithra Pharmaceuticals SA Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 62.675
EPS (TTM) (€) -1.41
Beta 0
Volatility % 93.34
14-Day RSI 35.06
14-Day ATR (€) 0.028487
20-Day SMA (€) 0.251535
12-1 Month Momentum % -82.2
52-Week Range (€) 0.1636 - 3.15
Shares Outstanding (Mil) 66.91

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Mithra Pharmaceuticals SA Filings

Filing Date Document Date Form
No Filing Data

Mithra Pharmaceuticals SA Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Mithra Pharmaceuticals SA Frequently Asked Questions

What is Mithra Pharmaceuticals SA(FRA:1TM)'s stock price today?
The current price of FRA:1TM is €0.23. The 52 week high of FRA:1TM is €3.15 and 52 week low is €0.16.
When is next earnings date of Mithra Pharmaceuticals SA(FRA:1TM)?
The next earnings date of Mithra Pharmaceuticals SA(FRA:1TM) is 2024-09-26 Est..
Does Mithra Pharmaceuticals SA(FRA:1TM) pay dividends? If so, how much?
Mithra Pharmaceuticals SA(FRA:1TM) does not pay dividend.

Press Release

Subject Date
No Press Release